An outbreak of acute hepatitis due to the hepatitis A virus in 2017: are we witnessing a change in contagion risk factors?

by Carlos Alventosa-Mateu, Juan-José Urquijo-Ponce, Moisés Diago-Madrid
Published 2018-10-01

Polycystic liver in the adult (PLA) in Spain: analysis of a structured survey analysing the experience and attitude of gastroenterologists in Spain

by Javier Ampuero, Jesús M. Bañales, Germán Soriano, Javier Crespo, José Luis Olcoz, Moisés Diago, José Luis Calleja, Manuel Romero-Gómez
Published 2014-04-01

One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infectio...

by Miriam Torrecillas, Neus Gómez-Muñoz, María Dolores Ocete, Purificación Rubio Cuevas, Moisés Diago Madrid, Enrique Ortega González, Concepción Gimeno Cardona, Miguel García-Deltoro
Published 2022-01-01

P-36 RESULTS OF AN AUTOMATIC ALERT SYSTEM FROM MICROBIOLOGY TO LINK DIAGNOSIS TO TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

by Carlos Alventosa Mateu, María Dolores Ocete Mochón, Juan José Urquijo Ponce, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Miguel García Deltoro, Enrique Ortega González, María José Bonet Igual, Concepción Gimeno Cardona, Moisés Diago Madrid
Published 2023-03-01

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

by Manuel Romero-Gómez, Juan Turnes, Javier Ampuero, Itziar Oyagüez, Beatriz Cuenca, Juan Gonzalez-Garcia, Belén Muñoz-Molina, Rocio Aguilar, Sandra Leal, Ramon Planas, Javier Garcia-Samaniego, Moises Diago, Javier Crespo, Jose Luis Calleja, Miguel Angel Casado, Ricard Sola
Published 2015-01-01

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

by Edward J. Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Mariliza Hendrique Da Silva, Henk Reesink, Igor Nikitin, Holger Hinrichsen, Stefan Bourgeois, Peter Ferenci, Umesh Shukla, Ronald Kalmeijer, Oliver Lenz, Bart Fevery, Chris Corbett, Maria Beumont, Wolfgang Jessner
Published 2017-06-01

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.

by Lai Wei, Heiner Wedemeyer, Yun-Fan Liaw, Henry Lik-Yuen Chan, Teerha Piratvisuth, Patrick Marcellin, Jidong Jia, Deming Tan, Wan-Cheng Chow, Maurizia R Brunetto, Moisés Diago, Selim Gurel, Viacheslav Morozov, Hua He, Yonghong Zhu, Cynthia Wat, Bernadette Surujbally, Alexander J Thompson
Published 2018-01-01

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4

by Juan José Urquijo, Moisés Diago, M.D., Jaume Boadas, Ramón Planas, Ricard Solá, Juan Angel del Olmo, Javier Crespo, José Carlos Erdozaín, María Dolores Antón, Carlos Arocena, Dolores Suarez, Josep Giné, Josep M Barrera, Javier Gracia-Samaniego, Ricardo Perez, Blai Dalmau, Miguel Montoro
Published 2013-01-01

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C

by Javier Ampuero, José A. Del Campo, Lourdes Rojas, José R. García-Lozano, Ricard Solá, Raúl Andrade, José A. Pons, José M. Navarro, José L. Calleja, María Buti, María F. González-Escribano, Xavier Forns, Moisés Diago, Javier García-Samaniego, Manuel Romero-Gómez, M.D., Ph.D.
Published 2014-07-01

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain

by Javier Crespo, MD, Ph.D., Moisés Diago, Joaquín Cabezas, Marina Berenguer, Teresa Broquetas, Miguel Ángel Serra, Rosa Morillas, Javier García-Samaniego, José Luis Calleja, Juan José Sánchez, Sabela Lens, Susana Soto-Fernández, Begoña Sacristán, Inmaculada Fernández, Carmen López-Núñez, María Buti, Manuel Romero-Gómez, Federico Sáez-Royuela, Conrado Fernández, Francisco Jorquera, Gloria Sánchez-Antolín, Juan Manuel Pascasio, Antonio Cuadrado, Manuel Hernández-Guerra
Published 2015-07-01

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

by Zobair M. Younossi, Saleh A. AlQahtani, Jesús Funuyet-Salas, Manuel Romero-Gómez, Yusuf Yilmaz, Caglayan Keklikkiran, Khalid Alswat, Ming-Lung Yu, Chun-Jen Liu, Jian-Gao Fan, Ming-Hua Zheng, Patrizia Burra, Sven M. Francque, Laurent Castera, Jörn M. Schattenberg, Philip N. Newsome, Alina M. Allen, Mohamed El-Kassas, Sombat Treeprasertsuk, Saeed Hameed, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Hirokazu Takahashi, Takumi Kawaguchi, Marlen I. Castellanos Fernández, Ajay Duseja, Marco Arrese, Mary Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Lynn Gerber, Brian Lam, Lisa Fornaresio, Fatema Nader, C. Wendy Spearman, Stuart K. Roberts, Wah-Kheong Chan, Marcelo Silva, Andrei Racila, Pegah Golabi, Prooksa Ananchuensook, Linda Henry, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus
Published 2024-07-01